These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 989411)

  • 1. [Study on the role of personality factors for successful lithium long-term therapy (author's transl)].
    Müller-Oerlinghausen B; Neumann H; Rüger U
    Arzneimittelforschung; 1976; 26(6):1181-3. PubMed ID: 989411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depth psychology aspects of the course of cyclothymic depressions during lithium prevention].
    Rüger U
    Nervenarzt; 1976 Sep; 47(9):538-43. PubMed ID: 823445
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in psychodynamics of manic-depressive diseases through the long-term administration of lithium salts].
    König L; Rossner M
    Pharmakopsychiatr Neuropsychopharmakol; 1974 Sep; 7(5):248-53. PubMed ID: 4216906
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy.
    Swartz HA; Pilkonis PA; Frank E; Proietti JM; Scott J
    Bipolar Disord; 2005 Apr; 7(2):192-7. PubMed ID: 15762861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening and evaluation on predictive factors in lithium carbonate maintenance treatment of manic-depressive disorders].
    Jiang ZN
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Dec; 23(6):324-8, 383. PubMed ID: 1982995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Determination of the erythrocytoplasma lithium ratio. Analytical considerations and clinical applications (author's transl)].
    Mahuzier G; Sylvestre G; Demaison J; Maccario J; Vu TD
    Pathol Biol (Paris); 1977 Nov; 25(9):629-36. PubMed ID: 341052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of clinical-chemical parameters under long-term lithium treatment.
    Müller-Oerlinghausen B; Drescher K
    Int J Clin Pharmacol Biopharm; 1979 May; 17(5):228-35. PubMed ID: 468448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation.
    Lepkifker E; Iancu I; Horesh N; Strous RD; Kotler M
    Depress Anxiety; 2007; 24(8):571-6. PubMed ID: 17133442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group therapy in addition to lithium therapy in patients with bipolar disorders.
    van Gent EM; Vida SL; Zwart FM
    Acta Psychiatr Belg; 1988; 88(5-6):405-18. PubMed ID: 3274891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A critical approach to prophylactic use of lithium in therapy for manic-depressive patients.
    De Martis D; Pavan F; Bezoari M; Ferro A; Gesué A
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):283-6. PubMed ID: 7107077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Report on efficacy of treatments for bipolar disorder.
    Gelenberg AJ; Hopkins HS
    Psychopharmacol Bull; 1993; 29(4):447-56. PubMed ID: 8084977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bipolar patients in remission: personality disorders and changes in personality].
    Kröber HL
    Nervenarzt; 1993 May; 64(5):318-23. PubMed ID: 8321340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transitory frequency increase and rhythmization of manic-depressive phases (5 weeks' cycle) during lithium long-term therapy].
    Michaelis R
    Nervenarzt; 1972 Aug; 43(8):437-8. PubMed ID: 5069870
    [No Abstract]   [Full Text] [Related]  

  • 17. [Objective studies on the differences in personality of monopolar and bipolar depressed patients treated with lithium].
    Czernik A; Steinmeyer EM; Samen A
    Nervenarzt; 1986 Sep; 57(9):517-25. PubMed ID: 3093907
    [No Abstract]   [Full Text] [Related]  

  • 18. [MAO-(monoamine oxidase-)inhibitor plus lithium. 1. Choice in psychopathologic rapidly changing bipolar manic-depressive patients (rapid cyclers)].
    Rogan M; Lesch OM; Schjerve M; Musalek M; Walter H
    Wien Klin Wochenschr; 1983 Jul; 95(14):498-502. PubMed ID: 6636782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term management of bipolar disorders with lithium, carbamazepine, and antidepressants.
    Fawcett J; Kravitz HM
    J Clin Psychiatry; 1985 Feb; 46(2):58-60. PubMed ID: 3968046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.